Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

SC Pharmaceuticals Inc (NQ: SCPH )

5.430 -0.080 (-1.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 435,716
Open 5.520
Bid (Size) 5.410 (4)
Ask (Size) 5.420 (6)
Prev. Close 5.510
Today's Range 5.230 - 5.550
52wk Range 3.240 - 7.550
Shares Outstanding 35,769,073
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SCPH Stock Earnings: scPharmaceuticals Misses EPS, Misses Revenue for Q2 2024
SCPH stock results show that scPharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Heart Failure-Focused scPharmaceuticals Secures FDA Approval For Expanded Use Of Furoscix, Receives Funding To Expand Commercialization
FDA approves scPharmaceuticals' expanded Furoscix indication to include NYHA Class IV heart failure patients. scPharmaceuticals secures $125M non-dilutive financing to repay debt and advance... 
Via Benzinga
Exposures Product Safety

Performance

YTD
-15.02%
-15.02%
1 Month
+6.16%
+6.16%
3 Month
+36.09%
+36.09%
6 Month
+1.12%
+1.12%
1 Year
-23.52%
-23.52%

More News

Read More
7 Short-Squeeze Stocks That Could Beat Down the Bears
Via InvestorPlace
SCPH Stock Earnings: scPharmaceuticals Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Recap: scPharmaceuticals Q4 Earnings
Via Benzinga
A Preview Of scPharmaceuticals's Earnings
Via Benzinga
Recap: scPharmaceuticals Q3 Earnings
Via Benzinga
Earnings Preview: scPharmaceuticals
Via Benzinga
Earnings Scheduled For March 13, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Earnings Outlook For scPharmaceuticals
Via Benzinga
The Latest Analyst Ratings for scPharmaceuticals
Via Benzinga
Analyst Ratings for scPharmaceuticals
Via Benzinga
Earnings Outlook For scPharmaceuticals
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
Via Benzinga
Dow Up 150 Points; Gold Jumps Over 2%
Via Benzinga
Earnings Preview For scPharmaceuticals
Via Benzinga
Earnings Scheduled For August 10, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Nasdaq Surges Over 2%; Accenture To Reduce 19,000 Jobs
Via Benzinga
KB Home, Accenture, Netflix And Other Big Stocks Moving Higher On Thursday
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.